论文部分内容阅读
胶质瘤是由神经外胚层衍化而来的胶质细胞所发生的肿瘤,其中Ⅰ级和Ⅱ级属于低级别胶质瘤(LGGs),可由多种原因导致较高的临床复发率、致残率、病死率。目前虽然LGGs的治疗仍存在较大争议,尚缺乏询证医学证据支持的疗效确切的治疗方法,但近年来随着基础及临床研究的进展,在显微手术技巧、手术辅助手段、放化疗方式制订等方面取得了较大的突破,LGGs治疗经验的积累越发丰富,手术、放化疗疗效及患者生存质量均得到了很大程度的提高。
Glioma is a tumor derived from glial cells derived from neuroectoderm. Grade I and II belong to low grade glioma (LGGs), which may lead to higher clinical relapse rate and disability due to various reasons Rate, fatality rate. At present, although the treatment of LGGs is still controversial, there is still a lack of effective curative treatment methods supported by evidence of medical evidence. However, with the progress of basic and clinical researches in recent years, there are still many problems in microsurgical techniques, surgical aids, radiotherapy and chemotherapy Made a breakthrough in the development and so on, LGGs more accumulated experience in the treatment of accumulation, surgery, radiotherapy and chemotherapy and patient quality of life have been greatly improved.